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Fig. 1. Pulsed Doppler ultrasonogram of the left eye of dogs. The
waveform of the medial long posterior ciliary artery is evident.
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  Color Doppler imaging (CDI) was carried out to evaluate 
the effects of anti-glaucoma drugs on ophthalmic circulation 
u s i n g  C D I - d e r i v e d  r e s i s t i v e  i n d e x  ( R I )  v a l u e s .  C D I  w a s  
performed  on  nine  Beagle  dogs,  and  RI  values  were 
calculated  for  the  medial  long  posterior  ciliary  artery 
before  and  after  the  administration  of  anti-glaucoma 
drugs. A significant increase in RI values was found after 
topical administration of levobunolol (p ＜ 0.05) or dipivefrin 
(p  ＜ 0.05).  Pilocarpine  showed  no  effects  on  RI  values 
after topical administration. The results suggest that some 
anti-glaucoma drugs could affect ophthalmic blood flow.
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Many investigator demonstrated that a number of topical 
medications may influence the blood flow to the eye 
[9,10].  β-blockers and sympathomimetics may affect 
blood flow because an imbalance is produced between the 
influence of the α and β sympathetic receptors on the 
ocular vasculature. The effect of this imbalance has often 
been difficult to ascertain and differing results have been 
found in various studies [10]. In humans, numerous orbital 
and ocular vessels have been mapped and their blood 
velocity parameters and waveforms have been 
characterized by using color Doppler imaging (CDI) [1,5]. 
A few veterinary reports have evaluated CDI of the canine 
orbit and eye [7]. This study was performed to assess the 
effect of anti-glaucoma drugs on the RI of the medial long 
posterior ciliary artery (mLPCA) using CDI, and to 
determine which anti-glaucoma drug was effective in 
reducing the intraocular pressure (IOP) without any 
changes in choroidal vascular resistance. 
Nine healthy Beagle dogs (three males and six females) 
weighing between 9.8 and 12.6 kg, with ages between 2- 
and 3-years old were used. All dogs were sexually intact 
and all examinations were applied to only the left eyes. 
Dogs were determined to be normal based on physical 
examination, complete blood count, serum biochemical 
analyses, and ophthalmic examinations. There were no 
signs of orbital diseases or neuro-ophthalmologic diseases 
in any dog. Animal care and experiments were carried out 
adhering to a guide for the care and use of laboratory 
animals from Gyeongsang National University, Korea. 
We used an ultrasonography (SSA-660; Toshiba, Japan) 
with a 10 MHz linear probe. Our technique for color 
Doppler imaging has been previously described [7]. 
Briefly, the left eyes and orbits were imaged with the dog 
lightly restrained in a sitting position. Coupling gel was 100    Hojung Choi et al.
Table 1. Effects of anti-glaucoma drugs on resistive index (RI) of the medial long posterior ciliary artery and intraocular pressure (IOP)
after topical applications
Drug
RI IOP
0 h 2 h 4 h 0 h 2 h 4 h
Levobunolol 0.67 ± 0.03
a 0.71 ± 0.06 0.75 ± 0.08
b 19.20 ± 6.64 17.70 ± 3.93 16.24 ± 4.55
Dipivefrin 0.68 ± 0.02
a 0.77 ± 0.06
b 0.72 ± 0.07 18.93 ± 4.60 16.59 ± 4.02 14.87 ± 4.78
Pilocarpine 0.70 ± 0.07 0.70 ± 0.07 0.71 ± 0.07 19.04 ± 5.32 18.91 ± 6.36 14.63 ± 6.52
a,bStatistical significance between a and b within rows (p ＜ 0.05). All data represent mean ± SD.
applied to the region dorsal to the left zygomatic arch, and 
the transducer was positioned in a horizontal plane (Fig. 1). 
Baseline measurements were performed in a predetermined 
order (IOP, RI of mLPCA). Thereafter, one drop of the 
medication was topically administered into the left eye. 
Measurements were repeated 120 and 240 min after 
administration. Single doses of the following drugs were 
administered topically into the left eye with nasolacrimal 
occlusion: 0.5% levobunolol (Betagan; Allergan 
Pharmaceuticals, Ireland), 0.1% dipivefrin (Propine; 
Allergan Pharmaceuticals, Ireland), and 4% pilocarpine 
(Samil Pharm, Korea). All dogs (nine left eyes) were used 
for experiments involving each drug. Withdrawal periods 
between each drug were greater than 14 days. Tonopen-XL 
(Mentor, USA) was used to measure IOP. The mean of 
three IOP measurements was calculated. 
Statistical analysis was performed using the SPSS 
statistical computer program (IBM, USA). A repeated 
measure ANOVA was used for data analysis. For all tests, 
p values ＜ 0.05 were considered significant. 
Effects of the anti-glaucoma drugs on RI values and IOP 
are presented in Table 1. All drugs under study relatively 
reduced IOP although the differences were not statistically 
significant. Topical administration of pilocarpine had no 
significant influence on the RI of mLPCA. However, 
levobunolol (post 4 h; p ＜ 0.05) and dipivefrin (post 2 h; 
p  ＜  0.05) significantly increased the RI of mLPCA 
following administration. 
Like timolol, levobunolol is a non-selective β-blocker 
which lowers IOP, probably by decreasing the secretion of 
aqueous humor by ciliary epithelium [2]. Bloom et al. [2] 
suggested that levobunolol had a variable effect on human 
retinal circulation with a tendency to produce a slightly 
overall increase in flow. Another study has shown that 
ocular blood flow change was not observed with 
levobunolol in humans [9]. However, in our study, 
levobunolol increased mLPCA RI, suggesting a decrease 
in the velocity of blood flow in the treated eye. It is not 
certain why these differences were observed. 
Dipivefrin directly acts as an α and β agonist. This drug, 
which is metabolized to epinephrine by corneal estrases, 
has been shown to reduce blood flow in the ciliary body in 
humans [8]. The direct vascular effect, together with the 
increase in uveoscleral outflow, may contribute to the 
intraocular pressure-reducing capability of dipivefrin [9]. 
Our data suggests that dipivefrin lowers choroidal blood 
flow. These results align with the finding of a slight 
decrease in choroidal blood flow after topical application 
of epinephrine in rabbits [6]. 
Theoretically, cholinergic miotics cause contraction of 
the longitudinal ciliary musculature and sphincter muscle 
of iris [3]. Ciliary muscle fibers are attached to the 
corneoscleral trabecular meshwork. Contraction of the 
ciliary muscle results in opening of the extratrabecular 
spaces of the corneoscleral trabecular meshwork and then 
increases drainage of an aqueous humor [4]. In our study, 
pilocarpine had no effect on ocular blood flow, which 
concurs with the results from a previous human study [9]. 
Another investigation reported using a radioactive 
microsphere technique with similar results in rabbits [6]. 
This group suggested that although the difference is not 
statistically significant, pilocarpine decreases blood flow 
to the iris and ciliary process. In our opinion, these trends 
may result from indirect compression by muscle contraction. 
We found that some anti-glaucoma drugs could affect 
ophthalmic blood flow, even though it is not known 
whether these effects are detrimental to the eye. Further 
studies are under way to investigate which anti-glaucoma 
treatments lower IOP while increasing ophthalmic blood 
flow, and whether effects on ophthalmic vascular 
resistance are detrimental or beneficial to eye. 
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